1. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G: Stimulation of Bone Formation in Vitro and in Rodents by HMG coA reductase inhibitors. Science. 1999, 286: 1946-9. 10.1126/science.286.5446.1946.
2. Russell RG, Robers MJ, Frith JC, et al: The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res. 1999, 14: 53-65.
3. Fisher JE, Halasy JM, Masarachia PJ, Wesolowiski G, Rodan GA, Reszka AA: Alendronate mechanism of action: inhibition of osteoclastogenesis and bone resorption are mimicked by lovastatin and blocked by geranygeraniol. Bone. 1998, 23 (Suppl): S399-
4. Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Harris F, Duong T, Cummings SR: HMG coA reductase inhibitor Use, Bone Mass and Fracture: An Analysis of Two Prospective Studies. J Bone Miner Res. 1999, 14 (suppl 1): S179-
5. Chan KA, Andrade SE, Boles M, Buist DSM, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R: Inhibitors of hydroxymethylgutaryl-coenzyme A reductase and risk of fracture among older women. Lancet. 2000, 355: 2185-8. 10.1016/S0140-6736(00)02400-4.